Evidence map›Paper›PMID 33965601›Full record

ReviewPhotodiagnosis and photodynamic therapy2021

SARS-CoV-2, hemoglobin and protoporphyrin IX: Interactions and perspectives.

Lilia Coronato Courrol, Flávia Rodrigues de Oliveira Silva, Valdivel Masilamani

Abstract readReview
In one paragraph

Review in Photodiagnosis and photodynamic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Long COVID as a Tauopathy: Of "Brain Fog" and "Fusogen Storms".International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lilia Coronato CourrolDepartamento de Física, Universidade Federal de São Paulo, Diadema, São Paulo, Brazil. Electronic address: lcourrol@unifesp.br.
Flávia Rodrigues de Oliveira SilvaCentro de Ciências e Tecnologia dos Materiais, Instituto de Pesquisas Energéticas e Nucleares, IPEN/CNEN-SP, SP, Brazil.
Valdivel MasilamaniKing Saud University, Physics and Astronomy Department, Laser Group, College of Science, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 attacks hemoglobin through its structural protein ORF3a, dissociating the iron from the heme, as iron is necessary by cell machinery for virus replication. In this process protoporphyrin (PpIX) is released.

methodsThe decrease in the hemoglobin levels observed in patients with Covid-19 is frequently accompanied by an increase in PpIX levels. This evidence was confirmed by the quantification of PpIX by high-performance liquid chromatography (HPLC). PpIX emission is observed in its two characteristic bands at approximately 635 nm and 705 nm.

resultsThis paper searches to understand the role of heme and PpIX inside the cells. Perspectives on the use of PpIX fluorescence as a sensor to monitor the presence of SARS-CoV-2 in the tissue, blood, urine, or feces to map the evolution and severity of the disease or to monitor the response of the Covid-19 treatment modalities were described.

conclusionFluorescence spectroscopy could be adopted as an excellent diagnostic technique for Covid-19, of low cost and high sensitivity. This method can potentially be used as a marker to monitor the response to the treatments. Photodynamic and sonodynamic therapies using the endogenous PpIX increased in the acute phase of the disease, could be employed for Covid-19 treatment.

Indexed as

COVID-19 Drug TreatmentPhotochemotherapyAminolevulinic AcidHemoglobinsHumansPhotosensitizing AgentsProtoporphyrinsSARS-CoV-2Aminolevulinic AcidHemoglobinsPhotosensitizing Agentsprotoporphyrin IXProtoporphyrinsCovid-19FluorescenceHemoglobinProtoporphyrin IX

Identifiers

PMID33965601
PMCPMC8123386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.